Read + Share
Ferrante M, Irving PM, Abreu MT, Axler J, et al. Maintenance Risankizumab Sustains Induction Response in Patients with Crohn's
Disease in a Randomized Phase 3 Trial. J Crohns Colitis 2023 Oct 5:jjad168. doi: 10.1093.
PMID: 37797293
|
 |
|
Ferrante M, Irving PM, Abreu MT, Axler J, et al. Maintenance Risankizumab Sustains Induction Response in Patients with Crohn's
Disease in a Randomized Phase 3 Trial. J Crohns Colitis 2023 Oct 5:jjad168. doi: 10.1093.
PMID: 37797293
|
|
|
|